@FierceMedDev: Blood test reveals more vivid GI cancer gene mutations. More | Follow @FierceMedDev
@MarkHFierce: The U.K. govt is supporting development of an anti-obesity electronic implant, at Imperial College London. Report | Follow @MarkHFierce
@DamianFierce: The AP has an excellent roundup of all that's happened with $ISRG over the past month or so. More | Follow @DamianFierce
> According to a study by the University of Texas, intrauterine devices are just as safe for teenagers as they are for adults, debunking long-believed myths about IUDs. More
> EndoEvolution, developer of minimally invasive suturing devices, closed a $5 million Series C. News
> Mallinckrodt, Covidien's ($COV) soon-to-be-spun-out drug business, is raising $900 million in senior notes to support the transition. Release
> IlluminOss Medical, maker of minimally invasive orthopedic systems, has appointed Dirk Kuyper president and CEO. Item
> Becton Dickinson ($BDX) won FDA clearance for its new C. difficile molecular diagnostic, using the BD Max assay platform. More
> CollabRx is teaming up with Sengenics to develop molecular diagnostics for the Asian market. News
> Medtronic ($MDT) has launched its CardioGuide implant system in the U.S. and Canada, touting the device as making the CRT implantation process easier and safer. Release
Biotech News
@FierceBiotech: FDA approved morning-sickness pill, to be marketed as Diclegis. Release | Follow @FierceBiotech
@JohnCFierce: Bristol-Myers' new R&D chief lays out PhIII game plan. More | Follow @JohnCFierce.
@RyanMFierce: Elsevier scoops up startup Mendeley in controversial bet on open science. Is it worth it? News | Follow @RyanMFierce
> Lundbeck touts promising head-to-head data on depression drug Brintellix. More
> NEA provides $10M to help fuel next-gen cancer R&D at Cleave. Report
> Gilead quickly asks FDA for blockbuster hep C approval. Story
Pharma News
@FiercePharma: CDC study finds U.S. adults still skipping their meds to save money. Until they qualify for Medicare. Report | Follow @FiercePharma
@EricPFierce: Fleming Laboratories has two plants in Pradesh, India, which were put on import alert Monday by the FDA. Alert | Follow @EricPFierce
> Amgen's two chiefs together net $22.7M in 2012 pay. More
> FDA approves morning-sickness drug withdrawn in 1980s safety scare. Item
> Union sues Warner Chilcott, Watson and Lupin over alleged pay-for-delay deal. Story
Pharma Manufacturing News
> China, India have yet to meet EU rule on APIs. More
> More Doxil made through J&J 'alternative manufacturing.' Report
> China drugmaker pulls flu treatment tainted with toxic herbs. Story
> Apotex recalls birth control pills. Article
Biotech Research News
@EmilyMFierce: Merck developing new class of drugs to target therapy-resistant cancer driven by genetic mutations. Report | Follow @EmilyMFierce
> Common sweetener mannitol improves motor functions in Parkinson's flies. More
> Targeted brain stimulation could treat addiction. Item
> New cancer radiation treatment has no harmful side effects in mice. Article
> Some still skeptical of BRAIN initiative as details remain fuzzy. Story